Assignee
PAMGENE BV
NL15 patents
Top patents by PatentIndex Score
US7364848B2Apr 29, 2008
Integrated microarray analysis
PAMGENE BV42 citations90
US6225131B1May 1, 2001
Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
PAMGENE BV38 citations89
US6383748B1May 7, 2002
Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same
PAMGENE BV30 citations88
US6338954B1Jan 15, 2002
Method for the non-specific amplification of nucleic acid
PAMGENE BV42 citations86
US6855539B2Feb 15, 2005
Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
PAMGENE BV13 citations81
US7473562B2Jan 6, 2009
Method for high-throughput integrated chemical and biochemical reactions
PAMGENE BV12 citations79
US6635493B2Oct 21, 2003
Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
PAMGENE BV9 citations71
US6864102B2Mar 8, 2005
Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
PAMGENE BV4 citations60
US6849408B2Feb 1, 2005
Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same
PAMGENE BV4 citations58
US7504209B2Mar 17, 2009
Method and device for integrated nucleic acid integrity assessment and analysis
PAMGENE BV3 citations52
US6886409B2May 3, 2005
System for controlling the flow of a fluid through a substrate
PAMGENE BV4 citations50
US7105134B2Sep 12, 2006
Device for holding a substrate
PAMGENE BV0 citations45
US12545946B2Feb 10, 2026
Method for predicting the response of melanoma patients to a medicament
PAMGENE BV0 citations38
US11802315B2Oct 31, 2023
Method for predicting the response of non-small-cell lung carcinoma patients to a medicament
PAMGENE BV0 citations37
US10604786B2Mar 31, 2020
Method for predicting the response of melanoma patients to targeted pharmacotherapy
PAMGENE BV0 citations30